Similar articles

• Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

  Dubreuil L, Breuil J, Dublanchet A, Sedallian A. Dubreuil L, et al. Eur J Clin Microbiol Infect Dis. 1992 Nov;11(11):1094-9. doi: 10.1007/BF01967804. Eur J Clin Microbiol Infect Dis. 1992. PMID: 1295764
• Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.

  Betriu C, Culebras E, Gómez M, López F, Rodríguez-Avial I, Picazo JJ. Betriu C, et al. Antimicrob Agents Chemother. 2008 Jul;52(7):2686-90. doi: 10.1128/AAC.00081-08. Epub 2008 May 12. Antimicrob Agents Chemother. 2008. PMID: 18474575 Free PMC article.
• Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992.

  Tanaka-Bandoh K, Kato N, Watanabe K, Ueno K. Tanaka-Bandoh K, et al. Clin Infect Dis. 1995 Jun;20 Suppl 2:S352-5. doi: 10.1093/clinids/20.supplement_2.s352. Clin Infect Dis. 1995. PMID: 7548596
• A new potent beta-lactamase inhibitor, BRL 42715, with inherent activity against Bacteroides fragilis group strains.

  Aldridge KE. Aldridge KE. Clin Infect Dis. 1993 Jun;16 Suppl 4:S335-8. doi: 10.1093/clinids/16.supplement_4.s335. Clin Infect Dis. 1993. PMID: 8324143 No abstract available.
• Antimicrobial resistance in Bacteroides.

  Wexler HM, Finegold SM. Wexler HM, et al. J Antimicrob Chemother. 1987 Feb;19(2):143-6. doi: 10.1093/jac/19.2.143. J Antimicrob Chemother. 1987. PMID: 3553132 Review. No abstract available.